Stay updated with breaking news from Spyro mousses. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SCOTTSDALE, Ariz. (BUSINESS WIRE) Oligon™ Inc., an emerging biotechnology company developing a novel class of multimodal RNA therapeutics for the treatment of cancer and other diseases, announced today that Dr. Spyro Mousses, CEO and Co-Founder, Andrew Matricaria, CFO, and James Silver, COO, will participate in th. ....
Oligon Inc., an emerging biotechnology company developing a novel class of multimodal RNA therapeutics for the treatment of cancer and other complex diseases, announced today that Dr. Spyro Mousses, ....